Through its Precision Care Companion, McKesson wants to help oncologists bring personalized medicine to their patients ...

Valued at a market cap of $54.8 billion, Cencora, Inc. (COR) is a global healthcare solutions provider. Headquartered in ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” first quarter ...

The segment’s performance is expected to have remained strong in the first quarter as well, driven by growth in ...

Cencora COR -0.56% Get Free Report has outperformed the market over the past 5 years by 12.25% on an annualized basis ...

This article summarizes the most significant insider buying and selling activities reported on Wednesday for US stocks.

Drug distributors like Cardinal Health, Cencora and McKesson will play a key role in the drug supply chain, improving patient ...

Manufacturing Digital explores the top supply chains in the healthcare industry that ensure manufacturers can produce and ...

Cencora Inc. closed 3.50% below its 52-week high of $296.65, which the company reached on April 4th.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Shares of Cencora Inc. COR shed 1.95% to $281.16 Monday, on what proved to be an all-around grim trading session for the ...

Here is how Cencora (COR) and Intensity Therapeutics Inc. (INTS) have performed compared to their sector so far this year.